Clinical trial
Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis
NCT04002349 is registered in ClinicalTrials.gov with Beijing Tongren Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster Analysis
- Lead sponsor
- Beijing Tongren Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2019
- Completion date
- March 31, 2020
- Enrollment
- 80 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
determination of the efficacy of different medications for idiopathic rhinitis, impact of different medications on biomarkers of idiopathic rhinitis, safety and tolerance of different medications for idiopathic rhinitis